Clonal hematopoiesis in LGI1-antibody encephalitis

Area of Science:

• Neuroimmunology
• Hematology
• Genetics

Background:

• Leucine-rich glioma-inactivated 1 (LGI1)-antibody encephalitis (LGI1e) is a primary autoimmune encephalitis (AE) affecting older adults, characterized by memory loss and seizures.
• Clonal hematopoiesis (CH) involves the accumulation of mutations in hematopoietic stem cells, increasing risks for autoimmune disorders and malignancies.
• Clonal hematopoiesis of indeterminate potential (CHIP) represents an early stage of CH, with potential implications for age-related diseases.

Purpose of the Study:

• To investigate the association between CHIP and LGI1e.
• To determine if CHIP mutations are more prevalent in LGI1e patients compared to a control group.
• To explore the clinical characteristics and treatment outcomes of LGI1e patients with and without CHIP.

Main Methods:

• Targeted gene sequencing was performed on peripheral blood samples from 52 LGI1e patients to analyze 24 CHIP-associated genes.
• Results were compared to a matched healthy control cohort.
• Clinical data, laboratory findings, and immunotherapy responses were analyzed based on CHIP status.

Main Results:

• Three out of 52 LGI1e patients (5.8%) had functional ASXL1 gene mutations, a significantly higher prevalence than in the control cohort (1%, p=0.015).
• No significant differences were observed in clinical characteristics, laboratory results, or immunotherapy outcomes between LGI1e patients with and without CHIP.
• The ASXL1 mutation frequency in LGI1e patients suggests a potential link to the disease.

Conclusions:

• LGI1e exhibits a notable frequency of ASXL1 mutations within the CHIP analysis.
• These findings suggest that CHIP, specifically ASXL1 mutations, may play a role in the pathogenesis of LGI1e.
• Further investigation is warranted to elucidate the direct contribution of CHIP to autoimmunity and disease progression in LGI1e.